Exametazime

DB11179ApprovedSmall molecule

Exametazime is a diagnostic radiopharmaceutical agent commonly used for the preparation of Tc99m Exametazime injection. It acts as a chelating agent for the radioisotope technetium-99m to form a cationic complex.... It is used in the detection of altered regional cerebral perfusion and for the radiolabeling of autologous leukocytes.

Formula / weight: C₁₃H₂₈N₄O₂ · 272.393 g/mol (avg)
Code names: DL HM-PAO

Resolves to

Compound

UNIIG29272NCKLCAS105613-48-7ChEMBLCHEMBL1615781ChEBI31586

Clinical / RWD

RxNorm62153

Structure

InChIKeyBPNZYADGDZPRTK-UDUYQYQQSA-NSMILESC[C@@H](NCC(C)(C)CN[C@H](C)C(\C)=N\O)C(\C)=N\O

What you can answer from here — as of May 14, 2021

1Clinical trialPhase, status and sponsor resolved per trial

1Structured indicationCondition, population, route and combination as fields, not prose

23Marketed productsAcross 8 countries and 9 labellers

1+ReferenceStructured and connected to the statements they support

Which other approved drugs treat the same conditions as Exametazime, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account